Technical Analysis for ALLK - Allakos Inc.

Grade Last Price % Change Price Change
D 104.91 -2.99% -3.23
ALLK closed up 0.51 percent on Thursday, April 15, 2021, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ALLK trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish -2.99%
Narrow Range Bar Range Contraction -2.99%
NR7 Range Contraction -2.99%
Doji - Bearish? Reversal -2.99%
Up 3 Days in a Row Strength -2.99%
Slingshot Bearish Bearish Swing Setup -2.49%
Oversold Stochastic Weakness -2.49%
200 DMA Support Bullish 0.43%
Doji - Bullish? Reversal 0.43%
Lower Bollinger Band Walk Weakness 0.43%
Older End-of-Day Signals for ALLK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 2 hours ago
Down 2 % about 3 hours ago
Outside Day about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago
Rose Above Previous Day's High about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Allakos, Inc. is a clinical-stage biotechnology company, which is engaged in developing antibodies that selectively target mast cells and eosinophils. The Company's antibodies target receptor molecules present on the surface of immune effector cells, which are involved in allergy, inflammation and tissue damage. Its lead program is AK002, which is an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. The Company's AK002 is used in the treatment of various diseases with abnormal proliferation of mast cells, including eosinophilic gastritis (EG), indolent systemic mastocytosis, urticaria and allergic conjunctivitis.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biology Immunology Diseases Immune System Antibodies Inflammation Antibody Cell Biology Allergy Mastocytosis Systemic Mastocytosis Allergic Conjunctivitis Eosinophil Mast Cell

Is ALLK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 157.98
52 Week Low 55.51
Average Volume 234,802
200-Day Moving Average 103.58
50-Day Moving Average 121.51
20-Day Moving Average 110.99
10-Day Moving Average 108.13
Average True Range 5.65
ADX 34.1
+DI 12.77
-DI 26.78
Chandelier Exit (Long, 3 ATRs ) 107.23
Chandelier Exit (Short, 3 ATRs ) 118.25
Upper Bollinger Band 119.37
Lower Bollinger Band 102.61
Percent B (%b) 0.33
BandWidth 15.09
MACD Line -4.01
MACD Signal Line -4.03
MACD Histogram 0.0201
Fundamentals Value
Market Cap 5.68 Billion
Num Shares 52.5 Million
EPS -1.61
Price-to-Earnings (P/E) Ratio -67.17
Price-to-Sales 0.00
Price-to-Book 13.29
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 112.15
Resistance 3 (R3) 112.17 110.85 111.48
Resistance 2 (R2) 110.85 109.83 110.84 111.25
Resistance 1 (R1) 109.50 109.20 110.18 109.48 111.03
Pivot Point 108.18 108.18 108.52 108.17 108.18
Support 1 (S1) 106.83 107.16 107.51 106.81 105.25
Support 2 (S2) 105.51 106.53 105.50 105.03
Support 3 (S3) 104.16 105.51 104.80
Support 4 (S4) 104.14